BioSpace News Archive

Receptor Life Sciences (Receptor) today announced the appointments of Orrin Devinsky, M.D., Ph.D. and Stephen J. Hoffman, M.D., Ph.D. to its Board of Directors.

Octave Bioscience, the developer of a fully integrated care management platform for multiple sclerosis (MS) and other neurodegenerative diseases, today announced that it has named Maital Shemesh-Rasmussen as Chief Commercial Officer (CCO).

Celmatix Inc., the leading women’s health biotech focused uniquely on ovarian biology, today announced that Dr. Stephen Palmer has joined its Scientific Advisory Board

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced Dr. Bankole Johnson, founder and Chief Medical Officer of Adial, was honored to be a guest on The Black News Channel (BNC).

Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Don Hardison to the Company’s strategic advisory board.

Altasciences , working with the National Research Council of Canada (NRC), has qualified a quantitative serological assay for the detection of SARS-CoV-2 IgG antibodies, to support vaccine development in studies from discovery to Phase II.

- National scholarship awards $3,000 to 40 exceptional students living with cystic fibrosis (CF) for academic excellence, creativity and community involvement - Top 40 scholarship recipients compete for public votes to receive one of two $25,000 Thriving Student Scholarships, awarded to an undergraduate and a graduate student

NeuroLogica Corp. announced today the immediate availability of its SmartMSU™ with OmniTom® Elite CT scanner. This next-generation Mobile Stroke Unit (MSU) advances the technology available for stroke imaging on an ambulance that the company pioneered 10 years ago

The online conference takes place March 17 and 18 from 9:00 a.m. to 5:00 p.m. EST.

In addition, Dr. Bedu-Addo will participate in the “Cancer Immunotherapies: Fighting Cancer with the power of the Immune System” panel immediately following his presentation at 10:25am ET on Wednesday, March 24.